Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.47 USD | +0.76% | -1.50% | -18.90% |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company shows low valuation levels, with an enterprise value at 0.5 times its sales.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.90% | 836M | C+ | ||
+8.20% | 7.78B | D+ | ||
+10.20% | 6.52B | - | ||
-8.10% | 3.67B | D | ||
-13.13% | 3.44B | B- | ||
-14.57% | 1.17B | - | - | |
+8.34% | 934M | - | ||
-42.27% | 879M | B+ | ||
-16.45% | 802M | C+ | ||
+0.32% | 711M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- USNA Stock
- Ratings USANA Health Sciences, Inc.